2365-43-7 Usage
Uses
Used in Pharmaceutical Industry:
1H-purine-6-carboxylic acid is used as an intermediate in the synthesis of various pharmaceutical compounds, particularly those related to the treatment of gout and other purine metabolism disorders. Its presence in the synthesis process aids in the development of drugs that can effectively manage these conditions.
Used in Biochemical Research:
In the field of biochemistry, 1H-purine-6-carboxylic acid serves as an essential research tool for studying the structure, function, and interactions of purine-based molecules. It helps researchers understand the role of purines in cellular processes and their involvement in various diseases.
Used in Diagnostic Applications:
1H-purine-6-carboxylic acid can be utilized in the development of diagnostic tools and tests for detecting and monitoring purine-related disorders. Its presence in these diagnostic applications aids in the accurate identification of these conditions, enabling timely and effective treatment.
Used in Nutritional Supplements:
As a component of purine metabolism, 1H-purine-6-carboxylic acid may be used in the formulation of nutritional supplements designed to support healthy purine metabolism and overall well-being. These supplements can be beneficial for individuals with purine metabolism disorders or those at risk of developing such conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 2365-43-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,6 and 5 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2365-43:
(6*2)+(5*3)+(4*6)+(3*5)+(2*4)+(1*3)=77
77 % 10 = 7
So 2365-43-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H4N4O2/c11-6(12)4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H,11,12)(H,7,8,9,10)
2365-43-7Relevant academic research and scientific papers
HETEROCYCLIC COMPOUND
-
Paragraph 1131; 1132, (2016/06/28)
A compound represented by the formula (I): wherein each symbol is as described in the SPECIFICATION, or a salt thereof has a PDE2A inhibitory action, and is useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like.
HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS
-
Page/Page column 77, (2008/12/05)
The present invention relates generally to amide containing heterobicyclic containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-3 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13 and MMP-3 inhibitors.
